Wed, Sep 17, 2014, 12:36 PM EDT - U.S. Markets close in 3 hrs 24 mins

Recent

% | $
Quotes you view appear here for quick access.

ArQule Inc. Message Board

  • normsapicker normsapicker May 18, 2012 2:44 PM Flag

    Where is the smoking gun?

    There has to be something in the data that we've missed. I haven't had an opportunity yet to read everything word by word. I guess it's my homework for the weekend.

    Has anyone else surmised why the market has acted this way since the data came out? Is the overall survival rate not that much of a statistical improvement that the FDA wouldn't approve it? Has another company come out with data that has better results than Arqule? There has to be something that's been missed. Does anyone see immediate forthcoming news that can help the stock rebound?

    I've owned Arqule since it was a compound development company and every time I think it's on the verge of breaking out it tanks. My patience is running out. I wish I owned Vertex Pharmaceuticals (VRTX)instead, another local Boston biotech.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Did anybody told you that now-days financial markets are highly manipulate?

      Just look at AMLN and HGSI. As soon as they got buyout interests, these companies more than doubled in price.

      ARQL did not have any new data for the last 2-3 months, so traders and money-changers lost interest.

      Granted, ARQL management could put more spin to PR but they did not. In any case, it would not change much.

      As so the released trial results, they are good. As for competition, Roche has a poster stating they started MetMab in Ph III NSCLC. The rest had Ph II results with 8-20 pts.

    • I have no idea. Isn't completion of enrollment in a major ph3 study at least a mild accomplishment? I'm completely disgusted at this point. But gotta say Mr Pucci nailed the $7.30!! Those guys investing $m just a few weeks ago cannot be happy...we all know the risks with biotech, etc, etc...but nobody signs up for what has happened over the last few weeks.

 
ARQL
1.215-0.015(-1.22%)12:35 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.